Manufacturing: Pharmaceutical and biopharmaceutical manufacturing, scale-up, and related processes - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Manufacturing
Equipment and processing in pharma, biopharma, specialty & generic drug manufacturing. Aseptic processing, cytotoxic manufacturing, small & large molecules.

European Commission Releases Report on Customs Interventions

July 29, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

In 2009, the European Commission (EC) Customs Union seized 11,462,533 medicines and medical products for suspected violations of intellectual property (IP), according to the Commission's annual report on EU Customs Enforcement of Intellectual Property Rights, which was published last week.

Week of July 26, 2010: Company and People Notes: Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

July 29, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

Fast Locator 2010-2011 Index

July 28, 2010

View companies' outsourcing profiles from PharmTech's 2010 Outsourcing Resources Fast Locator Index in the following categories.

Fast Locator 2010-2011 Biomanufacturing

July 28, 2010

Companies' outsourcing profiles from PharmTech's 2010 Outsourcing Resources Fast Locator Index.

Nycomed and Pfizer Sue Generic Firms

July 22, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Teva's and Sun Pharmaceuticals' motion to overturn a verdict issued against them in April 2010 for patent infringement has been denied by a US court, leaving the companies at the mercy of pharma giants Pfizer and Nycomed, who have said they will "vigorously" pursue damage claims.

Week of July 19, 2010: Company and People Notes: Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

July 22, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

SOCMA Voices Concern over Chemical-Site Security Bill

July 22, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The Society of Chemical Manufacturers and Affiliates (SOCMA) expressed "strong concern" over legislation introduced in the US Senate earlier this month regarding chemical-site security.

Merck KGaA Acquires Millipore and Founds New Divisions

July 22, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck KGaA (Darmstadt, Germany), a global pharmaceutical and chemical company, completed its acquisition of Millipore (Billerica, MA), a life-science company, last Thursday for an aggregate purchase price of roughly EUR 5.2 billion ($6.7 billion).

July 2010 Editor's Picks: Products from Gems Sensors and Controls and Telstar

July 21, 2010
Equipment and Processing Report

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the July 2010 edition from Gems Sensors and Controls and Telstar.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is your main concern regarding the outsourcing of various services to emerging countries?
Safety and quality issues
Lack of regulation
Job losses in the West
The distance
I have no concerns
Safety and quality issues
34%
Lack of regulation
24%
Job losses in the West
14%
The distance
3%
I have no concerns
24%
View Results
Jim MillerOutsourcing OutlookJim Miller Be Careful for What You Wish
Patricia Van ArnumIngredients InsiderPatricia Van ArnumAugmenting Excipient Functionality
Faiz kermaniSpotlightFaiz Kermani Reducing the number of failures in early stage development
Faiz kermaniStatistical Solutions Lynn D. TorbeckOn the Verge of Significance: Why 5%?
FindPharma Custom Search
Click here